Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology

[Image: see text] Recent data suggest that the inhibition of arginase (ARG) has therapeutic potential for the treatment of a number of indications ranging from pulmonary and vascular disease to cancer. Thus, high demand exists for selective small molecule ARG inhibitors with favorable druglike prope...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Min, Zhang, Hongjun, Li, Derun, Childers, Matthew, Pu, Qinglin, Palte, Rachel L., Gathiaka, Symon, Lyons, Thomas W., Palani, Anandan, Fan, Peter W., Spacciapoli, Peter, Miller, J. Richard, Cho, Hyelim, Cheng, Mangeng, Chakravarthy, Kalyan, O’Neil, Jennifer, Eangoor, Padmanabhan, Beard, Adam, Kim, Hai-Young, Saurí, Josep, Gunaydin, Hakan, Sloman, David L., Siliphaivanh, Phieng, Cumming, Jared, Fischer, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436246/
https://www.ncbi.nlm.nih.gov/pubmed/34527178
http://dx.doi.org/10.1021/acsmedchemlett.1c00195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436246/
https://www.ncbi.nlm.nih.gov/pubmed/34527178
http://dx.doi.org/10.1021/acsmedchemlett.1c00195

Ejemplares similares